FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles LeVea

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Physiology

Signal Transduction

Co-author Network

Publications

TOP 3
Melanie Ongchin; Elizabeth Sharratt; Ivan Dominguez; Neka Simms; Jing Wang; Richard Cheney; Charles LeVea; Michael G Brattain; Ashwani Rajput
The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer.
Jing Wang; Ashwani Rajput; Julie L C Kan; Rebecca Rose; Xiao-Qiong Liu; Karen Kuropatwinski; Jennie Hauser; Alexander Beko; Ivan Dominquez; Elizabeth A Sharratt; Lisa Brattain; Charles LeVea; Feng-Lei Sun; David M Keane; Neil W Gibson; Michael G Brattain
Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.
Arvinder S Bir; Ahmad A Fora; Charles LeVea; Marwan G Fakih
Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles LeVea (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Melanie Ongchin; Elizabeth Sharratt; Ivan Dominguez; Neka Simms; Jing Wang; Richard Cheney; Charles LeVea; Michael G Brattain; Ashwani Rajput
The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer.
The Journal of surgical research 2009;156(2):250-6.
2009: Jing Wang; Ashwani Rajput; Julie L C Kan; Rebecca Rose; Xiao-Qiong Liu; Karen Kuropatwinski; Jennie Hauser; Alexander Beko; Ivan Dominquez; Elizabeth A Sharratt; Lisa Brattain; Charles LeVea; Feng-Lei Sun; David M Keane; Neil W Gibson; Michael G Brattain
Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.
The Journal of biological chemistry 2009;284(16):10912-22.
2009: Arvinder S Bir; Ahmad A Fora; Charles LeVea; Marwan G Fakih
Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes.
Anticancer research 2009;29(2):465-8.
2009: Milind Javle; Gary Yang; Chumy E Nwogu; Gregory E Wilding; Linda O'Malley; Sanjay Vinjamaram; Michael D Schiff; Hector R Nava; Charles LeVea; Kimberly R Clark; Joshua D Prey; Patrick F Smith; Lakshmi Pendyala
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
Cancer investigation 2009;27(2):193-200.
2009: Manpreet K Chadha; Alan Litwin; Charles LeVea; Renuka V Iyer; Gary Yang; Milind Javle; John F Gibbs
Surgical resection after TNFerade therapy for locally advanced pancreatic cancer.
JOP : Journal of the pancreas 2009;10(5):535-8.
2009: Anubha Bharthuar; Lori Pearce; Alan Litwin; Charles LeVea; Boris W Kuvshinoff; Renuka V Iyer
Metastatic pancreatic adenocarcinoma and renal cell carcinoma treated with gemcitabine and sunitinib malate. A case report.
JOP : Journal of the pancreas 2009;10(5):523-7.
2008: Marwan G Fakih; Kelli Bullarddunn; Gary Y Yang; Lakshmi Pendyala; Karoly Toth; Chris Andrews; Youcef M Rustum; Mary Ellen Ross; Charles LeVea; Ajithkumar Puthillath; Young-Mee Park; Ashwani Rajput
Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.
International journal of radiation oncology, biology, physics 2008;72(3):650-7.
2008: Milind Javle; Amitkumar Pande; Renuka V Iyer; Gary Yang; Charles LeVea; Gregory Wilding; Jennifer Black; Hector Nava; Chukwumere Nwogu
Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.
American journal of clinical oncology 2008;31(4):329-34.
2008: Ashwani Rajput; Ivan Dominguez San Martin; Rebecca Rose; Alexander Beko; Charles LeVea; Elizabeth Sharratt; richard mazurchuk; Robert M Hoffman; Michael G Brattain; Jing Wang
Characterization of HCT116 human colon cancer cells in an orthotopic model.
The Journal of surgical research 2008;147(2):276-81.
2008: Rashmi Pande; Annette Y. Sunga; Charles LeVea; Gregory E Wilding; Wiam Bshara; Mary Reid; Marwan G Fakih
Significance of signet-ring cells in patients with colorectal cancer.
Diseases of the colon and rectum 2008;51(1):50-5.
2007: Xiao-Ning Guo; Ashwani Rajput; Rebecca Rose; Jennie Hauser; Alexander Beko; Karen Kuropatwinski; Charles LeVea; Robert M Hoffman; Michael G Brattain; Jing Wang
Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model.
Cancer research 2007;67(12):5851-8.
2007: SHEFALI AGRAWAL; Boris W Kuvshinoff; Thaer Khoury; Jihnhee Yu; Milind Javle; Charles LeVea; Jeff Groth; Lionel J Coignet; John F Gibbs
CD24 expression is an independent prognostic marker in cholangiocarcinoma.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2007;11(4):445-51.
2007: Bhavna Gupta; Charles LeVea; Alan Litwin; Marwan G Fakih
Reversible grade 4 hyperbilirubinemia in a patient with UGT1A1 7/7 genotype treated with irinotecan and cetuximab.
Clinical colorectal cancer 2007;6(6):447-9.
2007: Jason Foster; Jennifer Black; Charles LeVea; Thaer Khoury; Boris W Kuvshinoff; Milind Javle; John F Gibbs
COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
Annals of surgical oncology 2007;14(2):752-8.
2007: A U Pande; Renuka V Iyer; A Rani; S Maddipatla; G Y Yang; Chukwumere E Nwogu; Jennifer D Black; Charles LeVea; Milind Javle
Epidermal growth factor receptor-directed therapy in esophageal cancer.
Oncology 2007;73(5-6):281-9.
2005: Ashwani Rajput; Charles LeVea; Marilyn Intengan; John Kane; John F Gibbs
Gastrointestinal stromal tumor: chondro-myxoid variant mimicking chondrosarcoma.
Sarcoma 2005;9(1-2):25-8.
2005: Thaer Khoury; Krishdeep S Chadha; Milind Javle; Kathleen A Donohue; Charles LeVea; Renuka V Iyer; Haruhiko Okada; Hiroki Nagase; Dongfeng Tan
Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.
International journal of gastrointestinal cancer 2005;35(3):171-7.
2004: Manpreet K Chadha; Charles LeVea; Milind Javle; Boris W Kuvshinoff; Rekha Vijaykumar; Renuka V Iyer
Anaplastic pancreatic carcinoma. A case report and review of literature .
JOP : Journal of the pancreas 2004;5(6):512-5.
2004: Milind Javle; Dongfeng Tan; Jihnhee Yu; Charles LeVea; Fengzhi Li; Boris W Kuvshinoff; John F Gibbs
Nuclear survivin expression predicts poor outcome in cholangiocarcinoma.
Hepato-gastroenterology 2004;51(60):1653-7.
2004: Charles LeVea; Jay E Reeder; Robert A Mooney
EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
Experimental cell research 2004;297(1):272-84.
2003: Robert A Mooney; Charles LeVea
The leukocyte common antigen-related protein LAR: candidate PTP for inhibitory targeting.
Current topics in medicinal chemistry 2003;3(7):809-19.
2002: Javelle R Symons; Charles LeVea; Robert A Mooney
Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes.
The Biochemical journal 2002;365(Pt 2):513-9.
2000: Charles LeVea; Carl T McGary; J R Symons; Robert A Mooney
PTP LAR expression compared to prognostic indices in metastatic and non-metastatic breast cancer.
Breast cancer research and treatment 2000;64(2):221-8.